Su Golder
NIHR Research Fellow

Profile

Biography

Su is a qualified information specialist with over 20 years' experience. She has worked in lots of different settings and has a wide breadth of experience in supporting systematic reviews of healthcare interventions. She has specialist expertise in systematic review methodology and systematic reviews of adverse effects and has taught in this field. Her PhD on optimising the retrieval of adverse effects data was funded by the MRC and has made an important contribution to the retrieval of information on adverse effects both nationally and internationally. Her current research is on the use of unpublished data, text mining and social media to maximise the efficiency and effectiveness of the retrieval of adverse effects data and has been funded by the National Institute for Health Research (NIHR) and began in January 2015 on a part-time basis. 

Qualifications

• BSc (Hons)
• MSc
• PhD
• FRSA 

Departmental roles

• Member of the Athena SWAN charter for women in science working group

Research

Overview

Su's research interests include information retrieval, systematic reviews, methodology, unpublished and difficult to locate data, and adverse effects of healthcare interventions.

Projects

• Golder S. 2015. Using unpublished data, text mining and social media to maximise the efficiency and effectiveness of the retrieval of adverse effects data. NIHR TCC: Post-Doctoral Fellowship.
• Higgins J, Reeves B, Sterne J, Savović J, Deeks J, Shepperd S, Waters E, Armstrong R, Waddington H, Golder S. 2015. Assessing risk of bias in non-randomized studies of interventions. Medical Research Council
• Jefferson T, Stewart L, Doshi P, Golder S, Boutron I, Lefebvre C, Heneghan C, Jones M. 2015 Interim guidance on the inclusion of clinical study reports and other regulatory documents in Cochrane Reviews. Cochrane Methods Innovation Fund (2) programme.
• Loke Y, Golder S, Vohra S. 2016 Development of guidance for the identification and quality assessment of adverse effects in systematic reviews. Cochrane Methods Innovation Fund (2) programme.

Past projects

• Gold Golder S. 2001 Evaluation and comparison of health technology assessment in Australia, New Zealand and the UK. Winston Churchill Fellowship
• Hempel S, Norman G, Golder S, Aguiar-Ibanez R, Eastwood A. 2006. Scoping review on the psychosocial interventions for carers of people with Parkinson’s Disease Parkinsons Disease Society (PDS)
• Golder S. 2007. Evaluating and optimising the retrieval of research evidence for systematic reviews of adverse effects. Funder: MRC Special Training Fellowship in Health Services Research and Health of the Public 
• Stewart L, Golder S, Higgins J, Mannion R. 2012. Systematic review and meta-analysis of the safety and efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2) in spinal fusion. Yale University Open Data Access (YODA) initiative.

Research group(s)

• Health Services and Policy

Collaborators

• Health Language Processing at University of Pennsylvania

Publications

Full publications list

• Su Golder's publication list

External activities

Memberships

• Member of the SuRe (Summarized Research in Information Retrieval) Info project team
• Committee member of the PRISMA Harms Extension Steering Group
• Co-convenor of the Cochrane Adverse Effects Methods Group
• Member of the Cochrane Information Retrieval Methods Group Member of the InterTASC Information Specialists' Sub-Group (ISSG)
• Member of the European Association for Health Information and Libraries (EAHIL)
• Fellow of the Royal Society of Arts (RSA)
• Member of the Delphi forum committee for PRESS (Peer Review of Electronic Search Strategies)

Invited talks and conferences

• Golder S. Where to Identify Information on Adverse Effects for a Systematic Review – A Methodological Overview. Pharma-Bio-Med. Seville Spain, 7-11 November 2010.
• Golder S. Finding and Incorporating Information on Adverse Effects. Systematic Reviews Issues and Updates Symposium (Syrius II). ScHARR, Univerisity of Sheffield, Sheffield. 21 March 2011.
• Golder S. The Performance of Adverse Effects Search Filters in MEDLINE and EMBASE. Pharma-Bio-Med 2013. Berlin, Germany, 3-5 November 2013.
• Golder S. The contribution of different information sources for adverse effects data. Pharma-Bio-Med. Berlin, Germany, 3-5 November 2013.
• Golder S. The performance of adverse effects search filters in MEDLINE and EMBASE. Presented at the InterTASC Information Specialists' working group meeting. National Institute for Health and Care Excellence (NICE), Manchester, UK, 4 Dec 2013.
• Golder S. Data Sources and Search Strategies for Identifying Adverse Effects for Systematic Reviews. Cochrane UK and Ireland Annual Symposium. Manchester, UK, 23-24 April 2014.
• Golder S. Data sources and search strategies for adverse effects data. Medical Librarian Association (MLA) Conference. Chicago, U.S. 19 May 2014.
• Golder S. Systematic reviews: Where and how to search for information on adverse effects. Embase Webinar. 25 June 2014.
• Golder S. Where to find information on adverse drug effects. InterTASC Information Specialists' Sub-Group (ISSG) Workshop. Exeter, UK. 9 July 2014.
• Golder S. Rising above the noise: the benefits and pitfalls of searching social media for adverse effects. Pharma-Bio-Med & BioSciences Information Conference & Exposition. Rome, Italy, 26-28 October 2014.
• Golder S. Sometimes its Trickier than it looks! – Citation searching and some invaluable sources to improve your searching. Pharma-Bio-Med & BioSciences Information Conference & Exposition. Rome, Italy, 26-28 October 2014.
• Golder S, Norman G, Loke Y. Systematic review on social media as a data source for information on adverse effects. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
• Golder S, Junqueira D, Zorzela L. Adverse effects in systematic reviews: challenges for formulating the question and searching for different studies and sources of information. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
• Zorzela L, Golder S, Junqueira D. Reporting adverse events in reviews and the PRISMA Harms. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
• Junqueira D, Golder S, Zorzela L. Terminology challenges for data extraction and analysis of data on adverse effects. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
• Golder S. Social media and unpublished data as a source of information on adverse effects. Health Sciences Seminar, University of York, UK, 11 November 2015.
• Golder S. Norman G, Loke Y. Can social media help us find out about the side effects of treatments? NIHR Trainees Meeting. Leeds. 24-25 November 2015.
• Golder S. Social media and unpublished data as a source of information on adverse effects. Presented at the InterTASC Information Specialists' working group meeting. National Institute for Health and Care Excellence (NICE), Manchester, UK, 3 December 2015.
• Golder S, Norman G, Reed D. Ethics of social media research: A protocol for a systematic review. Conference: Ethics and Social Media Research By Academy of Social Sciences. London, 21 March 2016.
• Golder S. Does searching social media for adverse event data improve patient outcomes? Embase Webinar. 27 April 2016.